|
시장보고서
상품코드
2021181
자동 주사기 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 범위 - 제품별, 용도별, 유통 채널별, 지역별Autoinjectors Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, Distribution Channel, and Geography |
||||||
자동 주사기 시장 규모는 2025년 35억 1,000만 달러에서 2034년까지 105억 달러로 확대할 것으로 예상되고 있으며, 2026-2034년에 CAGR 13.2%를 기록할 것으로 전망되고 있습니다. 자가 투여가 필요한 만성질환의 전 세계 유병률 증가, 알레르기 질환의 유병률 증가, 응급 아나필락시스 관리의 중요성은 자동 주사기 시장 확대에 기여하는 주목할 만한 요인입니다. 또한 디지털화 및 커넥티드 기능을 갖춘 오토인젝터의 보급이 진행되고 있으며, 새로운 치료 영역과 적응증 확대는 가까운 미래에 시장에 새로운 동향을 가져올 것으로 예상됩니다.
자동 주사기 시장의 주요 동향 중 하나는 치료 관리, 데이터 수집 및 환자의 복약 순응도를 향상시키는 디지털 연결 및 '스마트' 기능의 채택입니다. 2025년 9월, 미국 식품의약국(FDA)은 입소메드의 YpsoMate 자동주사기용 디지털 연결 애드온인 SmartPilot에 대해 510(k) 승인을 부여했습니다. 이는 자동 주사기 플랫폼용으로 특별히 설계된 동종 장치 중 FDA 승인을 받은 최초의 제품입니다. 이 디지털 솔루션은 주요 주사 데이터(예: 날짜, 시간, 주사 결과, 조작 실수 등)를 수집하여 블루투스를 통해 환자의 스마트폰으로 안전하게 전송함으로써 환자와 의료진 모두에게 자가주사의 안전성 향상과 실제 임상에서의 치료 지식 습득에 기여합니다. 이번 승인은 데이터베이스 셀프케어를 위한 규제 및 임상 환경의 변화를 보여주는 것으로, 투약 준수 여부를 실시간으로 추적하고 오류를 식별할 수 있게 해줍니다. 의료 시스템이 원격 진료와 분산형 모델을 중시하는 가운데, 연결 기능을 갖춘 자동 주사기는 원격의료와의 통합, 복약 순응도 모니터링, 전자 건강 기록(EHR)과의 통합 가능성을 지원하여 단순한 기계적 투여를 넘어 미래의 디바이스를 위한 기준을 제시합니다.
제품별 인사이트
제품별로 보면 자동주사기 시장은 일회용과 재사용으로 양분되어 있습니다. 2025년, 일회용 자동 주사기 부문은 자동 주사기 시장에서 큰 점유율을 차지했습니다. 일회용 자동 주사기 부문은 만성질환의 유병률 증가, 자가 투약 요법의 확산, 비용 효율적이고 안전하며 편리한 투약 솔루션에 대한 요구로 인해 2025년 세계 시장을 장악할 것으로 예상됩니다. 이러한 장치는 미리 충전되어 바로 사용할 수 있는 기능을 제공하고, 투약 오류의 위험을 줄이고, 환자의 복약 순응도를 향상시켜 환자, 재택 의료 제공자 및 전문 클리닉에 도움이 될 수 있습니다. 제조업체와 의료기관은 모바일 앱 연동, 용량 추적 분석, 복약 순응도 및 안전성 자동 모니터링 등 스마트 기술 통합을 통해 업무 효율화를 실현하고 있습니다. 선진국의 엄격한 규제 기준, 환자 안전 요구 사항 및 기술 발전의 가속화와 함께 일회용 자동 주사기가 선호되는 솔루션이 되었습니다. 한편, 재사용 가능한 디바이스는 아시아태평양과 중남미 신흥 시장에서 점차 확산되고 있습니다.
목차
제1장 개요
제2장 오토인젝터 시장 구도
제3장 경쟁 구도
제4장 자동 주사기 시장 - 주요 시장 역학
제5장 오토인젝터 시장 - 세계 시장 분석
제6장 오토인젝터 시장의 매출 분석 - 유형별
제7장 오토인젝터 시장의 매출 분석 - 용도별
제8장 자동 주사기 시장의 매출 분석 - 유통 채널
제9장 자동 주사기 시장 - 지역 분석
제10장 자동 주사기 시장의 업계 상황
제11장 오토인젝터 시장 - 주요 기업 개요
제12장 추가 분석 대상 기업 리스트
제13장 부록
KSAThe Autoinjectors market size is expected to grow from US$ 3.51 billion in 2025 to US$ 10.50 billion by 2034; it is projected to register a CAGR of 13.2% during 2026-2034. The rising global prevalence of chronic diseases requiring self administration, increased prevalence of allergic conditions and emergency anaphylaxis management are noteworthy factors contributing to the expansion of the autoinjectors market. Additionally, the increasing integration of digital and connected autoinjectors as well as a expansion into new therapeutic areas and broader indications are projected to bring new market drifts in the near future.
A key trend in the autoinjectors market is the adoption of digital connectivity and "smart" features that enhance therapy management, data capture, and patient adherence. In September 2025, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to SmartPilot, a digital connectivity add-on for Ypsomed's YpsoMate autoinjectors, the first FDA-cleared device of its kind designed specifically for autoinjector platforms. This digital solution captures key injection data (e.g., time, date, injection outcome, user errors) and transmits it securely to patients' smartphones via Bluetooth, helping to improve self-injection safety and real-world therapy insights for both patients and clinicians. The clearance marks a shift in the regulatory and clinical environment toward data-informed self-care, enabling real-time injection adherence tracking and error identification. As healthcare systems emphasize remote care and decentralized models, connected autoinjectors support telehealth integration, adherence monitoring, and potential integration with electronic health records, setting a standard for future devices that extend beyond simple mechanical delivery.
Product -Based Insights
Based on product, the autoinjectors market is bifurcated into disposable and reusable. In 2025, the disposable autoinjectors segment held a significant autoinjectors market share. The disposable autoinjectors segment dominated the global market during 2025 due to the rising prevalence of chronic diseases, self-administration therapy adoption, and the need for cost-effective, safe, and convenient delivery solutions. These devices benefit patients, home healthcare providers, and specialty clinics as they offer prefilled, ready-to-use functionality, reduce the risk of dosing errors, and enhance patient adherence. Manufacturers and healthcare organizations achieve operational efficiency through the integration of smart technologies, including connectivity with mobile apps, dose-tracking analytics, and automated monitoring for adherence and safety. The combination of strict regulatory standards, patient safety requirements, and growing technological advancements in developed regions has made disposable autoinjectors the preferred solution, while reusable devices are gradually gaining adoption in emerging Asia Pacific and South and Central America markets.
The World Health Organization, Centers for Disease Control and Prevention (CDC), International Diabetes Federation's 2025 Diabetes Atlas, Allergy & Asthma Network's 2023 data, World Allergy Organization (WAO) are among the primary and secondary sources referred to while preparing the autoinjectors market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Autoinjectors Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.5 PEST Analysis
- 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import-Export Analysis for Key Countries
- 2.7 Impact of Artificial Intelligence (AI)
- 2.8 Product or Technology Roadmap
- 2.9 Sustainability and ESG Trends
- 2.10 Patent Analysis
- 2.11 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Autoinjectors Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.2 Market Restraints
- 4.3 Market Opportunities
- 4.4 Future Trends
- 4.5 Impact of Drivers and Restraints
5. Autoinjectors Market - Global Market Analysis
- 5.1 Autoinjectors Market Revenue (US$ Million), 2021-2034
- 5.2 Autoinjectors Market Forecast and Analysis
6. Autoinjectors Market Revenue Analysis - Type
- 6.1 Autoinjectors Market Forecasts and Analysis by Type
- 6.1.1 Disposable Prefilled Syringes
- 6.1.1.1 Overview
- 6.1.1.2 Disposable Prefilled Syringes: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 6.1.2 Reusable Prefilled Syringes
- 6.1.2.1 Overview
- 6.1.2.2 Reusable Prefilled Syringes: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 6.1.1 Disposable Prefilled Syringes
7. Autoinjectors Market Revenue Analysis - Applications
- 7.1 Autoinjectors Market Forecasts and Analysis by Applications
- 7.1.1 Cancer
- 7.1.1.1 Overview
- 7.1.1.2 Cancer: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 7.1.2 Diabetes
- 7.1.2.1 Overview
- 7.1.2.2 Diabetes: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 7.1.3 Autoimmune Disease
- 7.1.3.1 Overview
- 7.1.3.2 Autoimmune Disease: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 7.1.4 Infectious diseases
- 7.1.4.1 Overview
- 7.1.4.2 Infectious diseases: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 7.1.5 Others
- 7.1.5.1 Overview
- 7.1.5.2 Others: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 7.1.1 Cancer
8. Autoinjectors Market Revenue Analysis - Distribution Channel
- 8.1 Autoinjectors Market Forecasts and Analysis by Distribution Channel
- 8.1.1 Hospital Pharmacy
- 8.1.1.1 Overview
- 8.1.1.2 Hospital Pharmacy: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 8.1.2 Retail Pharmacy
- 8.1.2.1 Overview
- 8.1.2.2 Retail Pharmacy: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 8.1.3 Online Channel
- 8.1.3.1 Overview
- 8.1.3.2 Online Channel: Autoinjectors Market - Revenue, 2021-2034 (US$ Million)
- 8.1.1 Hospital Pharmacy
9. Autoinjectors Market - Geographical Analysis
- 9.1 North America
- 9.1.1 North America Autoinjectors Market Overview
- 9.1.2 North America: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.1.3 North America: Autoinjectors Market - By Segmentation
- 9.1.3.1 Type
- 9.1.3.2 Applications
- 9.1.3.3 Distribution Channel
- 9.1.4 North America: Autoinjectors Market Breakdown by Countries
- 9.1.4.1 United States Market
- 9.1.4.1.1 United States: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.1.4.1.2 United States: Autoinjectors Market - By Segmentation
- 9.1.4.1.2.1 Type
- 9.1.4.1.2.2 Applications
- 9.1.4.1.2.3 Distribution Channel
- 9.1.4.2 Canada Market
- 9.1.4.2.1 Canada: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.1.4.2.2 Canada: Autoinjectors Market - By Segmentation
- 9.1.4.2.2.1 Type
- 9.1.4.2.2.2 Applications
- 9.1.4.2.2.3 Distribution Channel
- 9.1.4.3 Mexico Market
- 9.1.4.3.1 Mexico: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.1.4.3.2 Mexico: Autoinjectors Market - By Segmentation
- 9.1.4.3.2.1 Type
- 9.1.4.3.2.2 Applications
- 9.1.4.3.2.3 Distribution Channel
- 9.1.4.1 United States Market
- 9.2 Europe
- 9.2.1 Europe Autoinjectors Market Overview
- 9.2.2 Europe: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.3 Europe: Autoinjectors Market - By Segmentation
- 9.2.3.1 Type
- 9.2.3.2 Applications
- 9.2.3.3 Distribution Channel
- 9.2.4 Europe: Autoinjectors Market Breakdown by Countries
- 9.2.4.1 Germany Market
- 9.2.4.1.1 Germany: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.1.2 Germany: Autoinjectors Market - By Segmentation
- 9.2.4.1.2.1 Type
- 9.2.4.1.2.2 Applications
- 9.2.4.1.2.3 Distribution Channel
- 9.2.4.2 United Kingdom Market
- 9.2.4.2.1 United Kingdom: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.2.2 United Kingdom: Autoinjectors Market - By Segmentation
- 9.2.4.2.2.1 Type
- 9.2.4.2.2.2 Applications
- 9.2.4.2.2.3 Distribution Channel
- 9.2.4.3 France Market
- 9.2.4.3.1 France: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.3.2 France: Autoinjectors Market - By Segmentation
- 9.2.4.3.2.1 Type
- 9.2.4.3.2.2 Applications
- 9.2.4.3.2.3 Distribution Channel
- 9.2.4.4 Italy Market
- 9.2.4.4.1 Italy: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.4.2 Italy: Autoinjectors Market - By Segmentation
- 9.2.4.4.2.1 Type
- 9.2.4.4.2.2 Applications
- 9.2.4.4.2.3 Distribution Channel
- 9.2.4.5 Spain Market
- 9.2.4.5.1 Spain: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.5.2 Spain: Autoinjectors Market - By Segmentation
- 9.2.4.5.2.1 Type
- 9.2.4.5.2.2 Applications
- 9.2.4.5.2.3 Distribution Channel
- 9.2.4.6 Rest of Europe Market
- 9.2.4.6.1 Rest of Europe: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.2.4.6.2 Rest of Europe: Autoinjectors Market - By Segmentation
- 9.2.4.6.2.1 Type
- 9.2.4.6.2.2 Applications
- 9.2.4.6.2.3 Distribution Channel
- 9.2.4.1 Germany Market
- 9.3 Asia Pacific
- 9.3.1 Asia Pacific Autoinjectors Market Overview
- 9.3.2 Asia Pacific: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.3 Asia Pacific: Autoinjectors Market - By Segmentation
- 9.3.3.1 Type
- 9.3.3.2 Applications
- 9.3.3.3 Distribution Channel
- 9.3.4 Asia Pacific: Autoinjectors Market Breakdown by Countries
- 9.3.4.1 China Market
- 9.3.4.1.1 China: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.1.2 China: Autoinjectors Market - By Segmentation
- 9.3.4.1.2.1 Type
- 9.3.4.1.2.2 Applications
- 9.3.4.1.2.3 Distribution Channel
- 9.3.4.2 Japan Market
- 9.3.4.2.1 Japan: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.2.2 Japan: Autoinjectors Market - By Segmentation
- 9.3.4.2.2.1 Type
- 9.3.4.2.2.2 Applications
- 9.3.4.2.2.3 Distribution Channel
- 9.3.4.3 India Market
- 9.3.4.3.1 India: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.3.2 India: Autoinjectors Market - By Segmentation
- 9.3.4.3.2.1 Type
- 9.3.4.3.2.2 Applications
- 9.3.4.3.2.3 Distribution Channel
- 9.3.4.4 Australia Market
- 9.3.4.4.1 Australia: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.4.2 Australia: Autoinjectors Market - By Segmentation
- 9.3.4.4.2.1 Type
- 9.3.4.4.2.2 Applications
- 9.3.4.4.2.3 Distribution Channel
- 9.3.4.5 South Korea Market
- 9.3.4.5.1 South Korea: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.5.2 South Korea: Autoinjectors Market - By Segmentation
- 9.3.4.5.2.1 Type
- 9.3.4.5.2.2 Applications
- 9.3.4.5.2.3 Distribution Channel
- 9.3.4.6 Rest of Asia Pacific Market
- 9.3.4.6.1 Rest of Asia Pacific: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.3.4.6.2 Rest of Asia Pacific: Autoinjectors Market - By Segmentation
- 9.3.4.6.2.1 Type
- 9.3.4.6.2.2 Applications
- 9.3.4.6.2.3 Distribution Channel
- 9.3.4.1 China Market
- 9.4 Middle East and Africa
- 9.4.1 Middle East and Africa Autoinjectors Market Overview
- 9.4.2 Middle East and Africa: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.4.3 Middle East and Africa: Autoinjectors Market - By Segmentation
- 9.4.3.1 Type
- 9.4.3.2 Applications
- 9.4.3.3 Distribution Channel
- 9.4.4 Middle East and Africa: Autoinjectors Market Breakdown by Countries
- 9.4.4.1 Saudi Arabia Market
- 9.4.4.1.1 Saudi Arabia: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.4.4.1.2 Saudi Arabia: Autoinjectors Market - By Segmentation
- 9.4.4.1.2.1 Type
- 9.4.4.1.2.2 Applications
- 9.4.4.1.2.3 Distribution Channel
- 9.4.4.2 South Africa Market
- 9.4.4.2.1 South Africa: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.4.4.2.2 South Africa: Autoinjectors Market - By Segmentation
- 9.4.4.2.2.1 Type
- 9.4.4.2.2.2 Applications
- 9.4.4.2.2.3 Distribution Channel
- 9.4.4.3 United Arab Emirates Market
- 9.4.4.3.1 United Arab Emirates: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.4.4.3.2 United Arab Emirates: Autoinjectors Market - By Segmentation
- 9.4.4.3.2.1 Type
- 9.4.4.3.2.2 Applications
- 9.4.4.3.2.3 Distribution Channel
- 9.4.4.4 Rest of Middle East and Africa Market
- 9.4.4.4.1 Rest of Middle East and Africa: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.4.4.4.2 Rest of Middle East and Africa: Autoinjectors Market - By Segmentation
- 9.4.4.4.2.1 Type
- 9.4.4.4.2.2 Applications
- 9.4.4.4.2.3 Distribution Channel
- 9.4.4.1 Saudi Arabia Market
- 9.5 South and Central America
- 9.5.1 South and Central America Autoinjectors Market Overview
- 9.5.2 South and Central America: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.5.3 South and Central America: Autoinjectors Market - By Segmentation
- 9.5.3.1 Type
- 9.5.3.2 Applications
- 9.5.3.3 Distribution Channel
- 9.5.4 South and Central America: Autoinjectors Market Breakdown by Countries
- 9.5.4.1 Brazil Market
- 9.5.4.1.1 Brazil: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.5.4.1.2 Brazil: Autoinjectors Market - By Segmentation
- 9.5.4.1.2.1 Type
- 9.5.4.1.2.2 Applications
- 9.5.4.1.2.3 Distribution Channel
- 9.5.4.2 Argentina Market
- 9.5.4.2.1 Argentina: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.5.4.2.2 Argentina: Autoinjectors Market - By Segmentation
- 9.5.4.2.2.1 Type
- 9.5.4.2.2.2 Applications
- 9.5.4.2.2.3 Distribution Channel
- 9.5.4.3 Rest of South and Central America Market
- 9.5.4.3.1 Rest of South and Central America: Autoinjectors Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 9.5.4.3.2 Rest of South and Central America: Autoinjectors Market - By Segmentation
- 9.5.4.3.2.1 Type
- 9.5.4.3.2.2 Applications
- 9.5.4.3.2.3 Distribution Channel
- 9.5.4.1 Brazil Market
10. Autoinjectors Market Industry Landscape
11. Autoinjectors Market - Key Company Profiles
- 11.1 Becton Dickinson and Co
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Phillips-Medisize
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Gerresheimer AG
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 West Pharmaceutical Services Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 SHL Medical
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Ypsomed Holding AG
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Haselmeier GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Owen Mumford Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Stevanato Group SpA
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Nemera
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
12. List of Additional Companies Analyzed
- 12.1 List of Additional Companies Analyzed
13. Appendix
- 13.1 Glossary
- 13.2 Research Methodology and Approach
- 13.2.1 Secondary Research
- 13.2.2 Primary Research
- 13.2.3 Market Estimation Approach
- 13.2.3.1 Supply Side Analysis
- 13.2.3.2 Demand Side Analysis
- 13.2.4 Research Assumptions and Limitations
- 13.2.5 Currency Conversion
- 13.3 About The Insight Partners
- 13.4 Market Intelligence Cloud
